Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Carla Uslenghi"'
Publikováno v:
The Journal of Headache and Pain
A hypofunctionality of Gi proteins has been found in migraine patients. The fixed combination of indomethacin, prochlorperazine and caffeine (Indoprocaf) is a drug of well-established use in the acute treatment of migraine and tension-type headache.
Autor:
Maria Nicolodi, A. Aloisio, Carla Uslenghi, Leonardo Vecchiet, Marco Fonzari, Pierluigi Del Bianco, Federigo Sicuteri, Vincenzo Di Monda, Irene Grazioli
Publikováno v:
Headache: The Journal of Head and Face Pain. 43:835-844
Objective.—To compare the efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine suppositories with sumatriptan suppositories in the treatment of 2 consecutive migraine attacks of moderate or severe intensity in a multicent
Publikováno v:
Pharmacological Research. 46:245-250
The combination of indomethacin, caffeine, and prochlorperazine (hereinafter IndoProCaf) represents an effective antimigraine drug available on the Italian market. The aim of this study was to test the efficacy of the three active principles alone an
Publikováno v:
The journal of pain. 5(8)
Recently it has been proposed that the throbbing pain of migraine is mediated by sensitization of peripheral trigeminovascular neurons, and that cutaneous allodynia of migraine is mediated by sensitization of central trigeminovascular neurons, and, m
Publikováno v:
Pharmacological research. 50(3)
The antinociceptive effect of the D 2 antagonist prochlorperazine was examined in the mouse hot-plate and abdominal constriction tests. Prochlorperazine (1–2 mg kg −1 s.c./i.p.) produced an increase of the pain threshold in the mouse hot-plate te
Autor:
Anna Maria Speciale, Maurizio Di Mauro, Roberto Girardello, F. Condorelli, Roberto Di Marco, Carla Uslenghi, Ferdinando Nicoletti, Giuseppe Chisari, Pier Luigi Meroni
Publikováno v:
Università degli studi del Molise-IRIS
Wistar rats infected with Streptococcus pneumoniae (type III ATCC) rapidly develop an acute form of experimental lobar pneumonia (ELP) with death of 80–90% of the animals by 6 days after the infection. Prophylactic treatment of these animals with t